Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Zambon

Showing results (91-100 of 261) with videos related to

Pageof 27
Sort By:
Antiviral Therapy|January 25, 2006
Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 virusesFrederick Hayden, Alexander Klimov, Masato Tashiro, et al.
JMIR Public Health and Surveillance|March 28, 2022
Adverse Events of Interest Following Influenza Vaccination in the First Season of Adjuvanted Trivalent Immunization: Retrospective Cohort StudySimon de Lusignan, Ruby S M Tsang, Oluwafunmi Akinyemi, et al.
Antiviral Research|January 27, 2019
Prophylactic efficacy of a human monoclonal antibody against MERS-CoV in the common marmosetEmmie de Wit, Friederike Feldmann, Eva Horne, et al.
The Journal of Infection|November 7, 2020
Seropositivity and risk factors for SARS-CoV-2 infection in staff working in care homes during the COVID-19 pandemicThomas A J Rowland, Heather Whitaker, Anna Jeffery-Smith, et al.
BMJ Open|March 11, 2019
Serological surveillance of influenza in an English sentinel network: pilot study protocolSimon de Lusignan, Ray Borrow, Manasa Tripathy, et al.
Journal of Infection Prevention|February 16, 2024
A surveillance study of SARS-CoV-2 infection in immunosuppressed patientsDaniel Bradshaw, Kathryn Harrison, Emma Page, et al.
Influenza and Other Respiratory Viruses|March 15, 2026
The Development of Global Genomic Surveillance of Respiratory Syncytial Virus: Insights From 25 Project Countries, 2019-2023Obadiah Kenji, Fernando Motta, Thomas Williams, et al.
F1000Research|April 20, 2017
Evidence synthesis and decision modelling to support complex decisions: stockpiling neuraminidase inhibitors for pandemic influenza usageSamuel I Watson, Yen-Fu Chen, Jonathan S Nguyen-Van-Tam, et al.
Journal of Immunological Methods|June 26, 2017
Comparison of mucosal lining fluid sampling methods and influenza-specific IgA detection assays for use in human studies of influenza immunityThushan I de Silva, Victoria Gould, Nuredin I Mohammed, et al.
Influenza and Other Respiratory Viruses|November 27, 2025
Effectiveness of Influenza Vaccines and Duration of Protection Against Hospitalisation in England: 2022/2023 and 2023/2024 SeasonsHeather J Whitaker, Freja C M Kirsebom, Katie Hassell, et al.
Pageof 27

Showing results (91-100 of 261) with videos related to

Sort By:
Pageof 27
Antiviral Therapy|January 25, 2006
Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 virusesFrederick Hayden, Alexander Klimov, Masato Tashiro, et al.
JMIR Public Health and Surveillance|March 28, 2022
Adverse Events of Interest Following Influenza Vaccination in the First Season of Adjuvanted Trivalent Immunization: Retrospective Cohort StudySimon de Lusignan, Ruby S M Tsang, Oluwafunmi Akinyemi, et al.
Antiviral Research|January 27, 2019
Prophylactic efficacy of a human monoclonal antibody against MERS-CoV in the common marmosetEmmie de Wit, Friederike Feldmann, Eva Horne, et al.
The Journal of Infection|November 7, 2020
Seropositivity and risk factors for SARS-CoV-2 infection in staff working in care homes during the COVID-19 pandemicThomas A J Rowland, Heather Whitaker, Anna Jeffery-Smith, et al.
BMJ Open|March 11, 2019
Serological surveillance of influenza in an English sentinel network: pilot study protocolSimon de Lusignan, Ray Borrow, Manasa Tripathy, et al.
Journal of Infection Prevention|February 16, 2024
A surveillance study of SARS-CoV-2 infection in immunosuppressed patientsDaniel Bradshaw, Kathryn Harrison, Emma Page, et al.
Influenza and Other Respiratory Viruses|March 15, 2026
The Development of Global Genomic Surveillance of Respiratory Syncytial Virus: Insights From 25 Project Countries, 2019-2023Obadiah Kenji, Fernando Motta, Thomas Williams, et al.
F1000Research|April 20, 2017
Evidence synthesis and decision modelling to support complex decisions: stockpiling neuraminidase inhibitors for pandemic influenza usageSamuel I Watson, Yen-Fu Chen, Jonathan S Nguyen-Van-Tam, et al.
Journal of Immunological Methods|June 26, 2017
Comparison of mucosal lining fluid sampling methods and influenza-specific IgA detection assays for use in human studies of influenza immunityThushan I de Silva, Victoria Gould, Nuredin I Mohammed, et al.
Influenza and Other Respiratory Viruses|November 27, 2025
Effectiveness of Influenza Vaccines and Duration of Protection Against Hospitalisation in England: 2022/2023 and 2023/2024 SeasonsHeather J Whitaker, Freja C M Kirsebom, Katie Hassell, et al.
Pageof 27